CSRXP COMMENDS LAWMAKERS FOR REFOCUSING CRITICAL ATTENTION ON BIG PHARMA’S EGREGIOUS PRICE HIKES AND PRACTICES
Sep 30, 2020
House Committee on Oversight and Reform to Question Big Pharma Executives… Read More
© 2025 CSRXP- All Rights Reserved
Statements
CSRxP Commends Congressional Probe Of Big Pharma Giant’s Anti-Competitive Tactics and Egregious Pricing Practices
Sep 1, 2020
U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of… Read More
CSRXP APPLAUDS INCLUSION OF CREATES IN SPENDING DEAL; URGES CONGRESS TO KEEP WORKING TO HOLD BIG PHARMA ACCOUNTABLE, LOWER Rx PRICES
Dec 16, 2019
Passage of Bipartisan, Market-based CREATES Act Will Be A First Step in the… Read More
CSRXP APPLAUDS USMCA CHANGES TO PUT AMERICAN PATIENTS FIRST
Dec 10, 2019
Revisions to Historic Trade Deal Remove Big Pharma Carveout Washington… Read More
CSRxP Commends Administration for Commitment to DTC Advertising Rule
Aug 21, 2019
Applauds HHS For Appealing Ruling Against List Price Transparency Measure… Read More
Insulin Hearing Will Add To Drug Pricing Momentum On Capitol Hill
Apr 1, 2019
CSRxP Commends House Energy & Commerce Committee For Giving Voice To… Read More
CSRxP Statement on Potential Big Pharma Bailout
Sep 21, 2018
“Only Big Pharma would use bipartisan opioid legislation as another… Read More
CSRxP Statement On Exclusion Of Big Pharma Accountability Amendment In Appropriations Bill
Sep 13, 2018
House Misses Bipartisan Opportunity To Hold Big Pharma Accountable… Read More
CSRxP Urges FDA To Finalize Guidance Critical To Lower Drug Prices
Aug 23, 2018
The Campaign for Sustainable Rx Pricing (CSRxP) today joined more than a dozen… Read More
CSRxP Applauds Trump Administration’s Focus on Out-of-Control Drug Prices
Aug 21, 2018
CSRxP spokesman Will Holley released the following statement applauding the… Read More
CSRxP Letter of Support for Durbin-Grassley DTC Advertising Amendment
Aug 21, 2018
Last night, Senators Durbin and Grassley filed an amendment to the Labor-HHS… Read More
CSRxP Statement on CMS Changes to Medicare Part B
Aug 7, 2018
CSRxP spokesman Will Holley released the following statement following… Read More